期刊文献+

人4-1BBL胞外区基因的克隆与表达研究 被引量:7

Cloning and Expression of the Extracellular Domain of 4-1BBL
下载PDF
导出
摘要 用RTPCR方法从人单核THP1细胞系克隆人41BBL胞外区基因,将其重组到pAYZ表达载体中,构建成人41BBL胞外区基因表达载体。将该载体转化大肠杆菌16C9,获得稳定表达,表达产物主要以可溶性状态存在;SDSPAGE和Westernblot分析显示,其分子量约为22kD,与预期结果一致。这是首次在大肠杆菌中获得41BBL胞外区可溶性表达。生物学活性检测显示41BBL对于维持T淋巴细胞系因子释放非常有益,同时PI单染表明它能抑制Jurkat细胞的凋亡。这将在抗肿瘤免疫治疗中具有潜在应用前景。 RT-PCR was used to clone DNA fragment of the extracellular domain of 4-1BBL from human THP-1 cells (human monocyte), and the expression vector pAYZ4-1BBL was constructed by cloning the extracellular domain of 4-1BBL into the expression vector pAYZ. The extracellular domain of 4-1BBL was expressed in E. coli 16C9 and purified by affinity chromatography, SDS-PAGE and Western blot analysis showed that the relativae molecular weight of soluble 4-1BBL is 22kD which was consistent with the theoretically predicted value. So far as we know, it is the first time that the soluble expression of 4-1BBL in E. coli.was achieved 4-1BBL induced a significant release of IL-2 in stimulated Jurkat cells after 48h incubation, especially in the presence of tumor cell. At the same time the apoptosis level of Jurkat cell reduce more than 50%. In conclusion,4-1BBL may be useful in cancer immunotherapy.
出处 《生物工程学报》 CAS CSCD 北大核心 2005年第5期703-707,共5页 Chinese Journal of Biotechnology
基金 国家高技术研究发展计划项目(863)资助(No.2003AA215080) 天津市重大科技攻关经费资助(No.003119511)。~~
关键词 4-1BBL 协同刺激分子 原核表达 4-1BB ligand, costimulatory molecules, prokaryotic expression
  • 相关文献

参考文献9

  • 1Ye Z, Hellstrom I, Hayden-Ledbetter M, Dahlin A et al. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat Med, 2002,8(4) :343 - 348
  • 2Martinet O, Divino CM, Zang Y et al. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer. Gene Ther, 2002,9(12) :786 - 792
  • 3Schwarz H, Valbracht J, Tuckwell J et al. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages.Blood, 1995, 85(4): 1043 - 1052
  • 4Bukczynski J, Wen T, Watts TH. Costimulation of human CD28- T cells by 4-1BB ligand. Eur J Immunol, 2003,33(2) :446 - 454
  • 5Myers L, Takahashi C, Mittler RS et al. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering. Proc Natl Acad Sci USA, 2003,100(9) :5348 - 5353
  • 6Melero I, Bach N, Hellstrom KE et al. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand:synergy with the CD28 co-stimulatory pathway. Eur J Immunol,1998,28(3): 1116 - 1121
  • 7Li Q, Carr A, Ito F et al. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy. Cancer Res, 2003, 63(10) :2546 - 2552
  • 8刘银星,熊冬生,范冬梅,邵晓枫,许元富,朱祯平,杨纯正.抗CD20嵌合抗体片段Fab′突变体的表达和活性研究[J].生物工程学报,2003,19(3):272-276. 被引量:5
  • 9高瀛岱,熊冬生,许元富,彭晖,邵晓枫,杨纯正,朱祯平.抗CD3/抗Pgp微型双功能抗体的构建和表达[J].生物工程学报,2003,19(4):444-449. 被引量:18

二级参考文献14

  • 1SHEN D C YANG X F YANG C Yet al.Generation and characirization of monoclonal antibody againstHIT3a[J].Acta Academiae Medicinac Sinicac (中国医学科学院学报),199,15:157-162.
  • 2XIONG D S YANG C Z SHAO X Fet al.Generation and characterization of monoclonal antibodiesagainst P-glycoprolein(Pgp)[J]. Chin J HemoZo/( 中国血液学杂志),1999,20(6):326-327.
  • 3XUYF XIONGDS YANG C Z.The mutation of anti-CD3 antibody(H1T3a)gene and its ex-pression[J].Chin Jhematol(中国血液学杂志),2001,22(5):252-255.
  • 4HoUiger P, Prospero T, Winter G. "Diabodies" :Small bivalent anti-body fragment. Proc Ncal Acid Sci USA, 1993, 90:6444 - 6448.
  • 5Xu Y F, Yang C z, Zhu z P. Bispecific antibody and its clinical ap-plication in cancer. Chinese Science Bulletin, 2001, 46(5) :353 -358.
  • 6HoUiger P, Winter G. ~Diabodies": Small bivalent antibody frag-ment. Cancer lmmunol lmmm~her, 1997, 45:128- 130.
  • 7Zhu Z P, Zapata G, Shalaby R et a/. High level secretion of a hu-manized bispecilie diabody from Eschedchia coll. Bio/ter.hnolog-/,1996,14:192 - 196.
  • 8Yang C Z, Luan F J, Xiong D Set al. Multidrug resistance in leu-kemiccell llne K562/A02 induced by doxorubicin. Acta Phannaco-/og/ca S/n/ca, 1995,16(4) : 333 - 337.
  • 9Campbell A M. Fusion procedures. In: Laboratory Techniques inBiochemistry and Molecular Biology: Monoclonal Antibody Technolo-gy. Burden RH and Knippenberg PH(Eds). Elsevier, Amsterdam,1984,pp. 120 - 134.
  • 10Fidler I J. Critical determinants of cancer metastasis : ratinale for ther-apy. Cancer Chemother Pharmaco1,1999,43(Suppl) :$3 - $10.

共引文献21

同被引文献47

  • 1杨铭,高瀛岱,熊冬生,刘汉芝,邵晓枫,许元富,彭晖,杨纯正.抗Pgp/抗CD3微型双功能抗体裸鼠体内分布研究[J].中国肿瘤临床,2004,31(20):1182-1184. 被引量:3
  • 2李国强,王学浩,印洁,俞悦.同时表达4-1BBL B7.1及B7.2三个共刺激分子基因小鼠肝癌细胞系的建立和意义[J].中国肿瘤临床,2006,33(22):1261-1264. 被引量:3
  • 3Li Q,Carr A,Ito F,et al.Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy[J].Cancer Res,2003,63(10):2546~2552
  • 4Ye Z,Hellstrom I,Hayden-Ledbetter M,et al.Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB[J].Nat Med,2002,8(4):343~348
  • 5Martinet O,Divino CM,Zang Y,et al.T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastasis of breast cancer[J].Gene Ther,2002,9(12):786~792
  • 6Schwarz H,Valbracht J,Tuckwell J,et al.ILA,the human 4-1BB homologue,is inducible in lymphoid and other cell lineages[J].Blood,1995,85(4):1043~1052
  • 7Bukczynski J,Wen T,Watts TH.Costimulation of human CD28-T cells by 4-1BB ligand[J].Eur J Immunol,2003,33(2):446~454
  • 8Myers L,Takahashi C,Mittler RS,et al.Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering[J].Proc Natl Acad Sci USA,2003,100(9):5348~5353
  • 9Melero I,Bach N,Hellstrom KE,et al.Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand:synergy with the CD28 co-stimulatory pathway[J].Eur J Immunol,1998,28(3):1116~1121
  • 10Bukczynski J, Wen T, Watts TH. Costimulation of human CD28-T cells by 4-1BB ligand. Eur J Immunol, 2003, 33(2): 446--454.

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部